Search

Filters
Clear All
  • 20
  • 60
  • 2
  • 631

Phase

  • 1
  • 14
  • 14
  • 50
  • 6
  • 77
  • 5
  • 536
  • 649
  • 288

Found 713 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

B
Bradley N. Bohnstedt, MD
18 years - 80 years
All genders
Observational
To determine safety and occlusion rates when second-generation hydrogel coils are used in theuptured intracranial aneurysms.
N
Naga Chalasani, MD
18 years - 80 years
All genders
Observational
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions associated withumulation that ranges from benign, non-progressive liver fat accumulation to severever injury, cirrhosis, and liver failure. NAFLD is the most common liver disease in USdults and the second leading cause for liver transplantation in the US. The natural …
S
Sandeep Batra, MD
2 years - 25 years
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial investigates the best dose of vinblastine in combination withumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinibg children and young adults with low-grade glioma (a common type of brain) that has come back after prior treatment (recurrent) …
T
Thomas Casciani, MD
18 years or above
All genders
Interventional
The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODYdovascular Stent Graft for treatment of stenosis or occlusion within the dialysis accessutflow circuit
J
Joel Corvera, MD
18 years or above
All genders
Observational
The purpose of this registry is to collect safety and performance data on all commerciallyvailable Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard. Data will be collected both retrospectively and prospectively.
S
Sandeep Batra, MD
24 months - 18 years
All genders
Phase 2
Interventional
What is the purpose of this study?This trial studies the side effects of enasidenib and to see how well it works in treatingwith acute myeloid leukemia that has come back after treatment (relapsed) or has been difficult to treat with chemotherapy (refractory). Patients must also have a specific genetic change, …
A
Alan Breier, MD
16 years - 35 years
All genders
Interventional
The investigators propose to examine the effects of CSC services delivered via TH (CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes in a 12-month,domized trial.
G
Gregory Sokol, MD
20 years or below
Accepts healthy volunteer
All genders
The study investigators are interested in learning more about how drugs, that are given tohildren by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of thisudy is to evaluate the …
S
Sashidhar Sagi, MD
18 years or above
All genders
Observational
Innovative programs exist that suggest that care for people with chronic conditions iszed when patients and providers have the information they need at the point of care andver time, to engage in shared planning and execution of treatment goals and care plans. Thisject aims to build an Inflammatory Bowel Disease …
L
Linda DiMeglio, MD
30 months - 45 years
Accepts healthy volunteer
All genders
RationaleThe accrual of data from the laboratory and from epidemiologic and prevention trials hasved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, andharacterization of the early metabolic abnormalities in T1DM is steadily …
481 - 490 of 713